Mineralys Therapeutics Inc (NAS:MLYS)
$ 30.4 -0.050 (-0.16%) Market Cap: 2.68 Bil Enterprise Value: 2.03 Bil PE Ratio: 0 PB Ratio: 3.93 GF Score: 37/100

Mineralys Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript

Jun 09, 2026 / 06:40PM GMT
Release Date Price: $24.18 (+7.47%)
Unidentified Participant

Now to grab a handle off the top Next stop shot down Leo put the money down a little road You pay one more job or get it One shot goes crazy One for the road.

All right, let's kick off our next session.

It is my pleasure to be to host Mineral and Therapeutics. Here with me, John Tongleton and Adam Levy, CEO and CFO of the company. Gentlemen, welcome.

Always a pleasure to be hosting you guys for these events.

I appreciate the weather looking good this year.

Looking at the district compared to the first time we hope that we're -- I mean, there was a hurricane that went through.

Jon Congleton
Mineralys Therapeutics Inc - President, Chief Executive Officer, Director

We were talking about that earlier, yeah.

Unidentified Participant;Jon Congleton
Mineralys Therapeutics Inc - President, Chief Executive Officer,

So before we -- I have a lot of questions to ask, but before we go through that, I'll turn it to you for opening remarks.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot